



Market Value:
The global Swine Mycoplasma Vaccine market was valued at US$ 665.7 million in 2023 and is projected to reach US$ 1101.9 million by 2030, at a CAGR of 7.5% during the forecast period.
(2024-2030)

By Types:
Inactivated Vaccines
Live Vaccines
